FRAX 10-year fracture risk in rheumatoid arthritis assessed with and without bone mineral density – are we treating our patients under bDMARDs?M. Rato, Miguel Bernardes, F. Oliveira Pinheiro et al.|ARP Rheumatology|2023Cited by 2
POS0204 AUTOANTIBODIES AND SYSTEMIC LUPUS ERYTHEMATOSUS INDUCED BY ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY IN RHEUMATOID ARTHRITISD. Santos Oliveira, Lúcia Costa, A. Martins et al.|Annals of the Rheumatic Diseases|2021Cited by 1
AB0483 CAN WE PREDICT WHICH PATIENTS WITH SPONDYLOARTHRITIS WILL NEED DOSE ESCALATION OF SECUKINUMAB TO 300 mg MONTHLY?Diogo Fonsêca, Lúcia Costa, F. Oliveira Pinheiro et al.|Annals of the Rheumatic Diseases|2021Cited by 1
AB0825 TIME-COURSE CHANGE IN AXIAL MOBILITY IN PSORIATIC ARTHRITIS PATIENTS UNDER bDMARDM. Rato, L. Costa, F. Oliveira Pinheiro et al.|Annals of the Rheumatic Diseases|2020Cited by 1
Renal involvement in Behçet´s Disease: a rare clinical challenge.Bruno Miguel Fernandes, Lúcia Costa, Roberto Silva et al.|PubMed|2022Cited by 1